Edaravone, a free radical scavenger, retards the development of amygdala kindling in rats

Neuroscience Letters

Volumn 461, Issue 3, 2009, Pages 298-301

  Kamida, Tohru ^a   Abe, Eiji ^a   Abe, Tatsuya ^a   Ooba, Hiroshi ^a   Fujiki, Minoru ^a   Kobayashi, Hidenori ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Amygdala kindling; Antiepileptogenic effect; Edaravone; Free radical scavenger; Rat

Indexed keywords

NORPHENAZONE; SCAVENGER;

ADULT ANIMAL; AFTERDISCHARGE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG MEGADOSE; EPILEPSY; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SEIZURE;

ANIMALS; ANTICONVULSANTS; ANTIPYRINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY, TEMPORAL LOBE; FREE RADICAL SCAVENGERS; KINDLING, NEUROLOGIC; MALE; RATS; RATS, WISTAR;

EID: 67649989125     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.06.039     Document Type: Article

References (19)

1. Ando K., Nishi H., Watanabe T., Watanabe Y., Yuki S., Sugasawa K., Horii D., Ishibashi A., Kimura A., Nakano D., and Morinaga T. General pharmacological studies of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), a novel radical scavenging agent. Jpn. Pharmacol. Ther. 25 (1997) 213-243
2. Frantseva M.V., Perez Velazquez J.L., Tsoraklidis G., Mendonca A.J., Adamchik Y., Mills L.R., Carlen P.L., and Burnham M.W. Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy. Neuroscience 97 (2000) 431-435
3. Herberg L.J., Grottick A., and Rose I.C. Nitric oxide synthesis, epileptic seizures and kindling. Psychopharmacology (Berl.) 119 (1995) 115-123
4. Iwase T., Kobayashi K., Mutai M., and Miura M. Thirty-day intravenous toxicity study of MCI-186 in rats with a recovery period of 14-day. Jpn. Pharmacol. Ther. 25 (1997) pp39-55
5. Kamida T., Fujiki M., Ooba H., Anan M., Abe T., and Kobayashi H. Neuroprotective effects of edaravone, a free radical scavenger, on the rat hippocampus after pilocarpine-induced status epilepticus. Seizure 18 (2009) 71-75
6. Kato N., Sato S., Yokoyama H., Kayama T., and Yoshimura T. Sequential changes of nitric oxide levels in the temporal lobes of kainic acid-treated mice following application of nitric oxide synthase inhibitors and Phenobarbital. Epilepsy Res. 65 (2005) 81-91
7. Löscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 50 (2002) 105-123
8. Miyamoto R., Shimakawa S., Suzuki S., Ogihara T., and Tamai H. Edaravone prevents kainic acid-induced neuronal death. Brain Res. 1209 (2008) 85-91
9. Murashima Y.L., Yoshii M., and Suzuki J. Role of nitric oxide in the epileptogenesis of EL mice. Epilepsia 41 (2000) 195-199
10. Osawa M., Uemura S., Kimura H., and Sato M. Amygdala kindling develops without mossy fiber sprouting and hippocampal neuronal degeneration in rats. Psychiat. Clin. Neurosci. 55 (2001) 549-557
11. Otani H., Togashi H., Jesmin S., Sakuma I., Yamaguchi T., Matsumoto M., Kakehata H., and Yoshioka M. Temporal effects of edaravone, a free radical scavenger, on transient ischemia-induced neuronal dysfunction in the rat hippocampus. Eur. J. Pharmacol. 512 (2005) 129-137
12. Racine R. Modification of seizure activity by electrical stimulation. I. Afterdischarge threshold, Electroencephalogr. Clin. Neurophysiol. 32 (1972) 269-279
13. Rondouin G., Lerner-Natoli M., Manzoni O., Lafon-Cazal M., and Bockaert J. A nitric oxide (NO) synthase inhibitor accelerates amygdale kindling. Neuroreport 3 (1992) 805-808
14. Schmidt J. New aspects in the pharmacology of kindling implications for mechanism of action in kindling. Pol. J. Pharmacol. Pharm. 39 (1987) 527-536
15. Swanson L.W. Brain Maps: Structure of the Rat Brain. third ed. (2004), Elsevier Academic Press, USA
16. Watanabe T., Tanaka M., Watanabe K., Takamatsu Y., and Tobe A. Research and development of the free radical scavenger edaravone as a neuroprotectant. Yakugaku Zasshi 124 (2004) 99-111
17. Watanabe T., Yuki S., Egawa M., and Nishi H. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J. Pharmacol. Exp. Ther. 268 (1994) 1597-1604
18. Yoshida H., Yanai H., Namiki Y., and Fukatsu-Sasaki K. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev. 12 (2006) 9-20
19. Zhang N., Komine-Kobayashi M., Tanaka R., Liu M., Mizuno Y., and Urabe T. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36 (2005) 2220-2225